Cover Image
市場調查報告書

乳房攝影篩檢技術市場預測 ∼2021年:乳房X光攝影、MBI、PET-CT、CBCT、PEM、胸部MRI、胸部超音波、AWBU、胸部熱成像、光學影像

Breast Imaging Market by Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Thermography, Optical Imaging)) - Forecast to 2021

出版商 MarketsandMarkets 商品編碼 259907
出版日期 內容資訊 英文 151 Pages
訂單完成後即時交付
價格
Back to Top
乳房攝影篩檢技術市場預測 ∼2021年:乳房X光攝影、MBI、PET-CT、CBCT、PEM、胸部MRI、胸部超音波、AWBU、胸部熱成像、光學影像 Breast Imaging Market by Type (Ionizing Technologies (Mammography, Digital Mammography, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Thermography, Optical Imaging)) - Forecast to 2021
出版日期: 2016年05月11日 內容資訊: 英文 151 Pages
簡介

全球乳房攝影篩檢市場預計從2016年到2021年以8.5%的年複合成長率成長。北美和歐洲等先進地區雖然佔大幅度的佔有率,但預計今後5年亞太地區將記錄最大的9.5%的年複合成長率。該地區的成長,由於患者人口的增加和醫療支出的擴大,醫療基礎設施的改善,地區的新興各國政府對乳癌研究的高投資額,對乳癌的早期發現的宣導活動的實施等而受推動

本報告提供全球乳房攝影篩檢市場相關調查,市場及技術概要,影響市場成長因素及市場機會分析,各技術區分、地區/主要國家趨勢與市場規模的變化與預測,競爭環境與市場佔有率,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

  • 簡介
  • 目前方案
  • 未來展望
  • 總論

第4章 重要考察

  • 市場概要
  • 電離影像技術市場:各地區、類型
  • 非電離影像技術市場:各地區、類型

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進要素
    • 阻礙要素
    • 機會

第6章 市場分析:各類型

  • 簡介
  • 電離乳房攝影篩檢技術
    • FFDM (全視野數位乳房攝影)
    • 類比乳房X光攝影
    • 3D乳房斷層攝影
    • PET-CT
    • MBI/BSGI
    • CBCT
    • PEM
    • EIT (電力電阻斷層掃描)
  • 非電離胸部畫技術
    • 胸部超音波
    • 胸部MRI
    • 全胸部超音波 (AWBU: AUTOMATED WHOLE-BREAST ULTRASOUND)
    • 胸部熱成像
    • 光學影像

第7章 地區分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 信息
    • 其他
  • 其他地區

第8章 競爭環境

  • 概要
  • 策略性概要
  • 市場佔有率分析
  • 競爭情形、趨勢
    • 新產品的投入、升級、認證
    • 聯盟、協定、合作
    • 其他

第9章 企業簡介

  • HOLOGIC, INC.
  • GE HEALTHCARE
  • SIEMENS HEALTHCARE
  • PHILIPS HEALTHCARE
  • FUJIFILM Holdings
  • GAMMA MEDICA, INC.
  • 東芝
  • SONOCINE, INC.
  • AURORA IMAGING TECHNOLOGY, INC.
  • DILON TECHNOLOGIES, INC.

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 2554

The global breast imaging market is estimated to grow at a CAGR of 8.5% from 2016 to 2021. Although developed regions (such as North America and Europe) held large shares in the breast imaging market in 2015, the Asia-Pacific region is poised to grow at the highest CAGR of 9.5% in the next five years. Factors such as the rising patient population, increasing healthcare expenditure, improving healthcare infrastructure, high government spending in emerging APAC countries on breast cancer research studies, and implementation of several initiatives to create awareness about the early detection of breast cancer are driving the growth of the breast imaging market in this region.

The growth of the global breast imaging market is driven by factors such as the rising incidence of breast cancer globally, growing government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities, and launch of advanced breast imaging systems capable of detecting cancer in women with dense breast tissues. In addition, increasing demand for breast imaging in emerging Asian countries and technological innovation in breast cancer detection are expected to offer growth opportunities to market players. However, a number of factors such as the high installation cost of breast imaging systems, side effects of radiation exposure, and errors in breast cancer screening and diagnosis are expected to restrain the growth of the breast imaging market. Besides, stringent regulatory approval procedures and unfavorable reimbursement scenario in developing countries will further restrain the growth of this market in the coming years.

In this report, the breast imaging market has been segmented on the basis of type [covering ionizing breast imaging technologies (analog mammography, full-field digital mammography (FFDM), 3D breast tomosynthesis, positron emission tomography/computed tomography (PET/CT), molecular breast imaging/breast-specific gamma imaging (MBI/BSGI), cone-beam computed tomography (CBCT), positron emission mammography (PEM), and electric impedance tomography) and non-ionizing breast imaging technologies (including breast MRI, breast ultrasound, automated whole-breast ultrasound (AWBU), breast thermography, and optical imaging)]; and region [North America (U.S., and Canada), Europe (Germany, France, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World]. The ionizing breast imaging technologies segment is estimated to account for the larger share of the global breast imaging market in 2016. However, the non-ionizing breast imaging technologies segment is expected to grow at the highest CAGR during the forecast period. The advantages offered by non-ionizing breast imaging technologies over ionizing breast imaging technologies, such as lower risk of radiation exposure, greater anatomical details for diagnosis, higher sensitivity to small breast lesions in women with dense breast tissues, and lower false positives are driving the growth of this market segment.

Geographically, North America is estimated to command the largest share of 43.8% of the global breast imaging market in 2016, followed by Europe. The large share of the North American region is attributed to the widespread adoption of newer techniques, such as 3D breast tomosythesis, breast MRI, molecular breast imaging, and automated whole-breast ultrasound (AWBU). A number of factors, such as the rising incidence of breast cancer, favorable reimbursement scenario, ongoing technological advancements by market players, implementation of new breast density notification law in the U.S., rapid growth in geriatric population, and growing demand for the use of low levels or negligible radiation doses are further stimulating the growth of the breast imaging market in North America. However, high cost of breast screening and limited availability of some radioactive isotopes are negatively affecting the growth of the breast imaging market in this region.

Hologic, Inc. (U.S.), GE Healthcare (U.K.), and Siemens Healthcare (Germany) were the top three players in the breast imaging market in 2015. These companies together accounted for 74.0% of the global market. Product launches, upgrades, and approvals; and partnerships, agreements, and collaborations are the major strategies adopted by most market players to achieve growth in the breast imaging market.

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis- market share analysis of the top players and company profiles, which together comprise and discuss basic views on the competitive landscape; emerging and high-growth segments of the breast imaging market; and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on breast imaging offered by the top 10 players in the breast imaging market. The report analyzes the breast imaging market by type across four geographies
  • Product Development/Innovation: Detailed insights on current technologies, research and development activities, and new product launches in the breast imaging market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various breast imaging products across four geographies (North America, Europe, Asia-Pacific, and Rest of the World)
  • Competitive Assessment: Assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the breast imaging market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Breakdown of primaries
      • 2.1.2.2. Key data from primary sources
      • 2.1.2.3. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
      • 2.2.1.1. Bottom-up approach
      • 2.2.1.2. Top-down approach
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. RESEARCH ASSUMPTIONS

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. BREAST IMAGING MARKET OVERVIEW
  • 4.2. BREAST IMAGING MARKET SHARE, BY TYPE, 2016 VS. 2021
  • 4.3. GEOGRAPHIC ANALYSIS: IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE
  • 4.4. GEOGRAPHIC ANALYSIS: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET, BY TYPE (2016)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
    • 5.1.1. MARKET SEGMENTATION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Growing prevalence of breast cancer
      • 5.2.1.2. Government investments and funding for breast cancer treatment and related research
      • 5.2.1.3. Increasing awareness about early detection of breast cancer
      • 5.2.1.4. Rapidly increasing aging population
      • 5.2.1.5. Technological advancements in breast imaging modalities
      • 5.2.1.6. Launch of advanced systems capable of detecting cancer in women with dense breast tissue
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High installation costs of breast imaging systems
      • 5.2.2.2. Side effects of radiation exposure
      • 5.2.2.3. Errors in breast cancer screening and diagnosis
      • 5.2.2.4. Stringent regulatory approval procedures
      • 5.2.2.5. Unfavorable reimbursement scenario in developing countries
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging economies offer high growth potential
      • 5.2.3.2. Technological innovations in breast cancer detection

6. BREAST IMAGING MARKET, BY TYPE

  • 6.1. INTRODUCTION
  • 6.2. IONIZING BREAST IMAGING TECHNOLOGIES
    • 6.2.1. FULL-FIELD DIGITAL MAMMOGRAPHY (FFDM)
    • 6.2.2. ANALOG MAMMOGRAPHY
    • 6.2.3. 3D BREAST TOMOSYNTHESIS
    • 6.2.4. POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT)
    • 6.2.5. MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING (MBI/BSGI)
    • 6.2.6. CONE-BEAM COMPUTED TOMOGRAPHY (CBCT)
    • 6.2.7. POSITRON EMISSION MAMMOGRAPHY (PEM)
    • 6.2.8. ELECTRIC IMPEDANCE TOMOGRAPHY
  • 6.3. NON-IONIZING BREAST IMAGING TECHNOLOGIES
    • 6.3.1. BREAST ULTRASOUND
    • 6.3.2. BREAST MRI
    • 6.3.3. AUTOMATED WHOLE-BREAST ULTRASOUND (AWBU)
    • 6.3.4. BREAST THERMOGRAPHY
    • 6.3.5. OPTICAL IMAGING

7. BREAST IMAGING MARKET, BY REGION

  • 7.1. INTRODUCTION
  • 7.2. NORTH AMERICA
    • 7.2.1. U.S.
    • 7.2.2. CANADA
  • 7.3. EUROPE
    • 7.3.1. GERMANY
    • 7.3.2. FRANCE
    • 7.3.3. U.K.
    • 7.3.4. REST OF EUROPE
  • 7.4. ASIA-PACIFIC
    • 7.4.1. JAPAN
    • 7.4.2. CHINA
    • 7.4.3. INDIA
    • 7.4.4. REST OF APAC
  • 7.5. REST OF THE WORLD (ROW)

8. COMPETITIVE LANDSCAPE

  • 8.1. OVERVIEW
  • 8.2. STRATEGIC OVERVIEW
  • 8.3. MARKET SHARE ANALYSIS
  • 8.4. COMPETITIVE SITUATION AND TRENDS
    • 8.4.1. PRODUCT LAUNCHES, UPGRADES, AND APPROVALS
    • 8.4.2. PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
    • 8.4.3. OTHER DEVELOPMENTS

9. COMPANY PROFILE

  • 9.1. INTRODUCTION
  • 9.2. HOLOGIC, INC.
    • 9.2.1. BUSINESS OVERVIEW
    • 9.2.2. PRODUCTS OFFERED
    • 9.2.3. RECENT DEVELOPMENTS
    • 9.2.4. MNM VIEW
  • 9.3. GE HEALTHCARE (A PART OF GENERAL ELECTRIC COMPANY)
    • 9.3.1. BUSINESS OVERVIEW
    • 9.3.2. PRODUCTS OFFERED
    • 9.3.3. RECENT DEVELOPMENTS
    • 9.3.4. MNM VIEW
  • 9.4. SIEMENS HEALTHCARE (A PART OF SIEMENS AG)
    • 9.4.1. BUSINESS OVERVIEW
    • 9.4.2. PRODUCTS OFFERED
    • 9.4.3. RECENT DEVELOPMENTS
    • 9.4.4. MNM VIEW
  • 9.5. PHILIPS HEALTHCARE (A PART OF KONINKLIJKE PHILIPS N.V.)
    • 9.5.1. BUSINESS OVERVIEW
    • 9.5.2. PRODUCTS OFFERED
    • 9.5.3. RECENT DEVELOPMENTS
    • 9.5.4. MNM VIEW
  • 9.6. FUJIFILM HOLDINGS CORPORATION
    • 9.6.1. BUSINESS OVERVIEW
    • 9.6.2. PRODUCTS OFFERED
    • 9.6.3. RECENT DEVELOPMENTS
    • 9.6.4. MNM VIEW
  • 9.7. GAMMA MEDICA, INC.
    • 9.7.1. BUSINESS OVERVIEW
    • 9.7.2. PRODUCTS OFFERED
    • 9.7.3. RECENT DEVELOPMENTS
  • 9.8. TOSHIBA CORPORATION
    • 9.8.1. BUSINESS OVERVIEW
    • 9.8.2. PRODUCTS OFFERED
    • 9.8.3. RECENT DEVELOPMENTS
  • 9.9. SONOCINE, INC.
    • 9.9.1. BUSINESS OVERVIEW
    • 9.9.2. PRODUCTS OFFERED
    • 9.9.3. RECENT DEVELOPMENTS
  • 9.10. AURORA IMAGING TECHNOLOGY, INC.
    • 9.10.1. BUSINESS OVERVIEW
    • 9.10.2. PRODUCTS OFFERED
  • 9.11. DILON TECHNOLOGIES, INC.
    • 9.11.1. BUSINESS OVERVIEW
    • 9.11.2. PRODUCTS OFFERED
    • 9.11.3. RECENT DEVELOPMENTS

10. APPENDIX

  • 10.1. DISCUSSION GUIDE*
  • 10.2. ADDITIONAL DEVELOPMENTS
    • 10.2.1. HOLOGIC, INC.
    • 10.2.2. GE HEALTHCARE (A PART OF GENERAL ELECTRIC COMPANY)
    • 10.2.3. PHILIPS HEALTHCARE (A PART OF KONINKLIJKE PHILIPS N.V.)
    • 10.2.4. SIEMENS HEALTHCARE (A PART OF SIEMENS AG)
    • 10.2.5. GAMMA MEDICA, INC
  • 10.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 10.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 10.5. AVAILABLE CUSTOMIZATIONS
  • 10.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: GROWING PREVALENCE OF BREAST CANCER TO TRIGGER MARKET GROWTH
  • TABLE 2: HIGH INSTALLATION COSTS OF BREAST IMAGING SYSTEMS TO RESTRAIN MARKET GROWTH
  • TABLE 3: EMERGING MARKETS OFFER SIGNIFICANT OPPORTUNITIES FOR MARKET PLAYERS
  • TABLE 4: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 5: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 6: GLOBAL FULL-FIELD DIGITAL MAMMOGRAPHY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: NORTH AMERICA: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 8: EUROPE: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 9: ASIA-PACIFIC: FULL-FIELD DIGITAL MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 10: GLOBAL ANALOG MAMMOGRAPHY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 11: NORTH AMERICA: ANALOG MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 12: EUROPE: ANALOG MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 13: ASIA-PACIFIC: ANALOG MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 14: GLOBAL 3D BREAST TOMOSYNTHESIS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: NORTH AMERICA: 3D BREAST TOMOSYNTHESIS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 16: EUROPE: 3D BREAST TOMOSYNTHESIS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 17: ASIA-PACIFIC: 3D BREAST TOMOSYNTHESIS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 18: GLOBAL POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: NORTH AMERICA: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 20: EUROPE: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 21: ASIA-PACIFIC: POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 22: GLOBAL MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: NORTH AMERICA: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 24: EUROPE: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 25: ASIA-PACIFIC: MOLECULAR BREAST IMAGING/BREAST-SPECIFIC GAMMA IMAGING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 26: GLOBAL CONE-BEAM COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: NORTH AMERICA: CONE-BEAM COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 28: EUROPE: CONE-BEAM COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 29: ASIA-PACIFIC: CONE-BEAM COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 30: GLOBAL POSITRON EMISSION MAMMOGRAPHY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 31: NORTH AMERICA: POSITRON EMISSION MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 32: EUROPE: POSITRON EMISSION MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 33: ASIA-PACIFIC: POSITRON EMISSION MAMMOGRAPHY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 34: GLOBAL ELECTRIC IMPEDANCE TOMOGRAPHY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 35: NORTH AMERICA: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 36: EUROPE: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 37: ASIA-PACIFIC: ELECTRIC IMPEDANCE TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 38: NON-IONIZING BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 39: GLOBAL BREAST ULTRASOUND MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 40: NORTH AMERICA: BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 41: EUROPE: BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 42: ASIA-PACIFIC: BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 43: GLOBAL BREAST MRI MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 44: NORTH AMERICA: BREAST MRI MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 45: EUROPE: BREAST MRI MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 46: ASIA-PACIFIC: BREAST MRI MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 47: GLOBAL AUTOMATED WHOLE-BREAST ULTRASOUND MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 48: NORTH AMERICA: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 49: EUROPE: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 50: ASIA-PACIFIC: AUTOMATED WHOLE-BREAST ULTRASOUND MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 51: GLOBAL BREAST THERMOGRAPHY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 52: NORTH AMERICA: BREAST THERMOGRAPHY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 53: EUROPE: BREAST THERMOGRAPHY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 54: ASIA-PACIFIC: BREAST THERMOGRAPHY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 55: GLOBAL OPTICAL IMAGING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 56: NORTH AMERICA: OPTICAL IMAGING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 57: EUROPE: OPTICAL IMAGING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 58: ASIA-PACIFIC: OPTICAL IMAGING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 59: BREAST IMAGING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 60: NORTH AMERICA: BREAST IMAGING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 61: NORTH AMERICA: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 62: NORTH AMERICA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 63: NORTH AMERICA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 64: U.S.: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 65: U.S.: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE 2014-2021 (USD MILLION)
  • TABLE 66: U.S.: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 67: CANADA: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 68: CANADA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 69: CANADA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 70: EUROPE: BREAST IMAGING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 71: EUROPE: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 72: EUROPE: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 73: EUROPE: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 74: GERMANY: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 75: GERMANY: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 76: GERMANY: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 77: FRANCE: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 78: FRANCE: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 79: FRANCE: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 80: U.K.: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 81: U.K.: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 82: U.K.: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 83: REST OF EUROPE: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 84: REST OF EUROPE: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 85: REST OF EUROPE: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 86: ASIA-PACIFIC: BREAST IMAGING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 87: ASIA-PACIFIC: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 88: ASIA-PACIFIC: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 89: ASIA-PACIFIC: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 90: JAPAN: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 91: JAPAN: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 92: JAPAN: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 93: CHINA: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 94: CHINA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2016-2021 (USD MILLION)
  • TABLE 95: CHINA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 96: INDIA: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 97: INDIA: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 98: INDIA: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 99: ROAPAC: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 100: ROAPAC: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 101: ROAPAC: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 102: ROW: BREAST IMAGING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 103: ROW: IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 104: ROW: NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 105: TOP 5 PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, 2013-2016
  • TABLE 106: TOP 5 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2013-2016
  • TABLE 107: TOP 5 OTHER DEVELOPMENTS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: BREAKDOWN OF DEMAND-SIDE PRIMARY INTERVIEWS: BY END USER AND REGION
  • FIGURE 4: BREAST IMAGING MARKET: BOTTOM-UP APPROACH
  • FIGURE 5: BREAST IMAGING MARKET: TOP-DOWN APPROACH
  • FIGURE 6: BREAST IMAGING MARKET: DATA TRIANGULATION
  • FIGURE 7: GLOBAL BREAST IMAGING MARKET SIZE, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 8: GLOBAL IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 9: GLOBAL NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SIZE, BY TYPE, 2016 VS. 2021 (USD MILLION)
  • FIGURE 10: GLOBAL BREAST IMAGING MARKET, BY REGION, 2016
  • FIGURE 11: EMERGING COUNTRIES OFFER HIGH-GROWTH OPPORTUNITIES FOR PLAYERS IN THE BREAST IMAGING MARKET
  • FIGURE 12: IONIZING BREAST IMAGING TECHNOLOGIES WILL CONTINUE TO DOMINATE THE GLOBAL BREAST IMAGING MARKET IN 2021
  • FIGURE 13: ASIA-PACIFIC 3D BREAST TOMOSYNTHESIS MARKET TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 14: BREAST ULTRASOUND SEGMENT DOMINATES THE NON-IONIZING BREAST IMAGING MARKET IN ALL REGIONS
  • FIGURE 15: BREAST IMAGING MARKET SEGMENTATION
  • FIGURE 16: BREAST IMAGING MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 17: BREAST IMAGING MARKET, BY TYPE, 2016 VS. 2021
  • FIGURE 18: FFDM TO COMMAND THE LARGEST SHARE OF THE IONIZING BREAST IMAGING TECHNOLOGIES MARKET IN 2016
  • FIGURE 19: NORTH AMERICA TO HOLD THE MAJOR SHARE OF THE FFDM MARKET IN 2016
  • FIGURE 20: ASIA-PACIFIC TO BE THE FASTEST-GROWING REGION IN THE 3D BREAST TOMOSYNTHESIS MARKET
  • FIGURE 21: AWBU: THE FASTEST-GROWING SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 22: EUROPE IS EXPECTED TO HOLD THE SECOND-LARGEST SHARE OF THE BREAST ULTRASOUND MARKET IN 2016
  • FIGURE 23: EUROPE TO HOLD SECOND-LARGEST SHARE OF THE AUTOMATED WHOLE-BREAST ULTRASOUND MARKET IN 2016
  • FIGURE 24: IONIZING AND NON-IONIZING BREAST IMAGING TECHNOLOGIES MARKET SHARE, BY COUNTRY, 2016
  • FIGURE 25: NORTH AMERICA: BREAST IMAGING MARKET SNAPSHOT 2016 AND 2021
  • FIGURE 26: U.S. BREAST DENSITY NOTIFICATION LAW, BY STATE, 2015
  • FIGURE 27: EUROPE: BREAST IMAGING MARKET SNAPSHOT 2016 AND 2021
  • FIGURE 28: ASIA-PACIFIC: BREAST IMAGING MARKET SNAPSHOT, 2016 AND 2021
  • FIGURE 29: ROW: BREAST IMAGING MARKET SNAPSHOT, 2016 AND 2021
  • FIGURE 30: LEADING MARKET PLAYERS ADOPTED PRODUCT LAUNCHES, UPGRADES, AND APPROVALS AS THEIR KEW GROWTH STRATEGY FROM 2013 TO 2016
  • FIGURE 31: GLOBAL BREAST IMAGING MARKET SHARE, BY KEY PLAYER, 2015
  • FIGURE 32: BATTLE FOR MARKET SHARE : PRODUCT LAUNCHES, UPGRADES, AND APPROVALS-KEY GROWTH STRATEGY ADOPTED BY PLAYERS BETWEEN 2013 & 2016
  • FIGURE 33: GEOGRAPHIC REVENUE MIX OF THE LEADING MARKET PLAYERS
  • FIGURE 34: HOLOGIC, INC.: COMPANY SNAPSHOT
  • FIGURE 35: GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
  • FIGURE 36: SIEMENS AG: COMPANY SNAPSHOT
  • FIGURE 37: KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • FIGURE 38: FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 39: TOSHIBA CORPORATION: COMPANY SNAPSHOT
Back to Top